177 related articles for article (PubMed ID: 34619398)
1. Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents.
Albert E; Burgos JS; Peiró S; Salas D; Vanaclocha H; Giménez E; Limón R; Alcaraz MJ; Sánchez-Payá J; Díez-Domingo J; Navarro D;
Clin Microbiol Infect; 2022 Feb; 28(2):279-284. PubMed ID: 34619398
[TBL] [Abstract][Full Text] [Related]
2. B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.
Torres I; Albert E; Giménez E; Alcaraz MJ; Botija P; Amat P; Remigia MJ; Beltrán MJ; Rodado C; Huntley D; Olea B; Navarro D
Clin Microbiol Infect; 2021 Nov; 27(11):1672-1677. PubMed ID: 34174397
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination.
Torres I; Bellido-Blasco JB; Gimeno C; Burgos JS; Albert E; Moya-Malo R; Gascó-Laborda JC; Tornero A; Soriano J; Meseguer-Ferrer N; Martínez-Serrano M; Ortíz-Rambla J; Buj H; Hernández N; Peiró S; Salas D; Limón R; Vanaclocha H; Sánchez-Payá J; Díez-Domingo J; Comas I; González-Candelas F; Navarro D;
J Med Virol; 2022 Aug; 94(8):3776-3782. PubMed ID: 35445415
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection.
Torres I; Giménez E; Albert E; Zulaica J; Álvarez-Rodríguez B; Burgos JS; Peiró S; Limón R; Vanaclocha H; Rodado C; Botija P; Sifre A; Tur B; Lozano RA; Orosa I; Vicente-Ruiz M; Carrión RJ; Clari MÁ; Sánchez-Payá J; Díez-Domingo J; Comas I; González-Candelas F; Geller R; Navarro D;
J Med Virol; 2022 Sep; 94(9):4216-4223. PubMed ID: 35585782
[TBL] [Abstract][Full Text] [Related]
5. Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study.
Tut G; Lancaster T; Krutikov M; Sylla P; Bone D; Kaur N; Spalkova E; Bentley C; Amin U; Jadir AT; Hulme S; Butler MS; Ayodele M; Bruton R; Shrotri M; Azmi B; Fuller C; Irwin-Singer A; Hayward A; Copas A; Shallcross L; Moss P
Lancet Healthy Longev; 2021 Sep; 2(9):e544-e553. PubMed ID: 34430954
[TBL] [Abstract][Full Text] [Related]
6. Strong Decay of SARS-CoV-2 Spike Antibodies after 2 BNT162b2 Vaccine Doses and High Antibody Response to a Third Dose in Nursing Home Residents.
Blain H; Tuaillon E; Gamon L; Pisoni A; Miot S; Picot MC
J Am Med Dir Assoc; 2022 May; 23(5):750-753. PubMed ID: 35311651
[TBL] [Abstract][Full Text] [Related]
7. Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination.
Tormo N; Giménez E; Martínez-Navarro M; Albert E; Navalpotro D; Torres I; Gimeno C; Navarro D
Eur J Clin Microbiol Infect Dis; 2022 Apr; 41(4):657-662. PubMed ID: 35165804
[TBL] [Abstract][Full Text] [Related]
8. Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status.
Helle F; Moyet J; Demey B; François C; Duverlie G; Castelain S; Bloch F; Brochot E
Vaccine; 2022 Jan; 40(3):531-535. PubMed ID: 34893341
[TBL] [Abstract][Full Text] [Related]
9. Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty® COVID-19 vaccine.
Giménez E; Alberola J; Torres I; Albert E; Alcaraz MJ; Botija P; Amat P; Remigia MJ; Beltrán MJ; Rodado C; Huntley D; Olea B; Navarro D
J Infect; 2022 Mar; 84(3):418-467. PubMed ID: 34740744
[No Abstract] [Full Text] [Related]
10. T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.
Schiavoni I; Palmieri A; Olivetta E; Leone P; Di Lonardo A; Mazzoli A; Cafariello C; Malara A; Palamara AT; Incalzi RA; Onder G; Stefanelli P; Fedele G;
J Am Med Dir Assoc; 2023 Feb; 24(2):140-147.e2. PubMed ID: 36587928
[TBL] [Abstract][Full Text] [Related]
11. Persistence and Protective Potential of SARS-CoV-2 Antibody Levels After COVID-19 Vaccination in a West Virginia Nursing Home Cohort.
Smoot K; Yang J; Tacker DH; Welch S; Khodaverdi M; Kimble W; Wen S; Amjad A; Marsh C; Perrotta PL; Hodder S
JAMA Netw Open; 2022 Sep; 5(9):e2231334. PubMed ID: 36098966
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal serologic and viral testing post-SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort-Georgia, October 2020‒April 2021.
Tobolowsky FA; Waltenburg MA; Moritz ED; Haile M; DaSilva JC; Schuh AJ; Thornburg NJ; Westbrook A; McKay SL; LaVoie SP; Folster JM; Harcourt JL; Tamin A; Stumpf MM; Mills L; Freeman B; Lester S; Beshearse E; Lecy KD; Brown LG; Fajardo G; Negley J; McDonald LC; Kutty PK; Brown AC;
PLoS One; 2022; 17(10):e0275718. PubMed ID: 36301805
[TBL] [Abstract][Full Text] [Related]
13. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
Vinh DC; Gouin JP; Cruz-Santiago D; Canac-Marquis M; Bernier S; Bobeuf F; Sengupta A; Brassard JP; Guerra A; Dziarmaga R; Perez A; Sun Y; Li Y; Roussel L; Langelier MJ; Ke D; Arnold C; Whelan M; Pelchat M; Langlois MA; Zhang X; Mazer BD;
Lancet Healthy Longev; 2022 Mar; 3(3):e166-e175. PubMed ID: 35224524
[TBL] [Abstract][Full Text] [Related]
14. Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine.
Giménez E; Albert E; Zulaica J; Torres I; Rusu L; Moreno AR; Burgos JS; Peiró S; Salas D; Vanaclocha H; Limón R; Alcaraz MJ; Sánchez-Payá J; Díez-Domingo J; Comas I; Gonzáles-Candelas F; Geller R; Navarro D;
Clin Infect Dis; 2022 Aug; 75(1):e865-e868. PubMed ID: 35314856
[TBL] [Abstract][Full Text] [Related]
15. Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the comirnaty COVID-19 vaccine in nursing home residents.
Sánchez-Sendra B; Albert E; Zulaica J; Torres I; Giménez E; Botija P; Beltrán MJ; Rodado C; Geller R; Navarro D
Sci Rep; 2022 Mar; 12(1):3788. PubMed ID: 35260713
[TBL] [Abstract][Full Text] [Related]
16. Anti-Spike SARS-CoV-2 IgG Assessment with a Commercial Assay during a 4-Month Course after COVID-19 Vaccination.
Swadźba J; Anyszek T; Panek A; Martin E
Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835298
[TBL] [Abstract][Full Text] [Related]
17. Pronounced antibody elevation after SARS-CoV-2 BNT162b2 mRNA booster vaccination in nursing home residents.
Chong Y; Goto T; Tani N; Yonekawa A; Ikematsu H; Shimono N; Tanaka Y; Akashi K
Influenza Other Respir Viruses; 2022 Nov; 16(6):1066-1071. PubMed ID: 35962568
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.
Meyers E; De Rop L; Deschepper E; Duysburgh E; De Burghgraeve T; Van Ngoc P; Digregorio M; Delogne S; Coen A; De Clercq N; Buret L; Coenen S; De Sutter A; Scholtes B; Verbakel JY; Cools P; Heytens S
Eur J Gen Pract; 2023 Dec; 29(2):2149732. PubMed ID: 36440533
[TBL] [Abstract][Full Text] [Related]
19. Evaluating immunity to SARS-CoV-2 in nursing home residents using saliva IgG.
Katz MJ; Heaney CD; Pisanic N; Smith L; Bigelow BF; Sheikh F; Boudreau A; Kruczynski K; Hsu YJ; Salinas AB; Cosgrove SE; Rock C
J Am Geriatr Soc; 2022 Mar; 70(3):659-668. PubMed ID: 35038344
[TBL] [Abstract][Full Text] [Related]
20. Immune Response 5-7 Months after Vaccination against SARS-CoV-2 in Elderly Nursing Home Residents in the Czech Republic: Comparison of Three Vaccines.
Martínek J; Tomášková H; Janošek J; Zelená H; Kloudová A; Mrázek J; Ježo E; Král V; Pohořská J; Šturcová H; Maďar R
Viruses; 2022 May; 14(5):. PubMed ID: 35632827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
